Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Pension (2016 - 2019)

Harvard Bioscience (HBIO) has disclosed Pension for 9 consecutive years, with $900000.0 as the latest value for Q2 2019.

  • On a quarterly basis, Pension fell 25.0% to $900000.0 in Q2 2019 year-over-year; TTM through Jun 2019 was $900000.0, a 25.0% decrease, with the full-year FY2018 number at $900000.0, down 25.0% from a year prior.
  • Pension was $900000.0 for Q2 2019 at Harvard Bioscience, roughly flat from $900000.0 in the prior quarter.
  • In the past five years, Pension ranged from a high of $4.6 million in Q2 2015 to a low of $900000.0 in Q4 2018.
  • A 5-year average of $2.6 million and a median of $2.8 million in 2015 define the central range for Pension.
  • Peak YoY movement for Pension: surged 30.77% in 2017, then tumbled 64.71% in 2018.
  • Harvard Bioscience's Pension stood at $2.8 million in 2015, then increased by 7.14% to $3.0 million in 2016, then tumbled by 60.0% to $1.2 million in 2017, then dropped by 25.0% to $900000.0 in 2018, then changed by 0.0% to $900000.0 in 2019.
  • Per Business Quant, the three most recent readings for HBIO's Pension are $900000.0 (Q2 2019), $900000.0 (Q4 2018), and $1.2 million (Q3 2018).